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Objectives. To conduct a feasibility study on a new, tablet-delivered treatment for
unusual sensory experiences in service-users with an At Risk Mental States for psychosis.
Design. A mixed method design was employed, using content analysis to investigate
whether service-users and therapists found the new treatment acceptable and helpful.
We also collected data on the impact of treatment, but without a control group could not
make any claims about effectiveness.
Methods. Eligible participantswere contacted before starting treatment andoffered the
chance to participate. Assessments were conducted before and after the treatment,
which typically was completed in 4–6 sessions by an accredited CBT therapist. A
structured interview was used to collect qualitative feedback.
Results. Qualitative feedback suggested that the treatment was acceptable to service-
users and therapists, and the progression criteria were met for recruitment, retention,
and adherence to treatment.
Conclusions. The new treatment targeting subtypes of auditory and visual hallucina-
tions was acceptable to service-users and the benefits of addressing psychological
mechanisms thought to contribute to hallucinations was supported by qualitative
feedback.
Practitioner points
 A novel treatment has been developed for unusual sensory experiences




 The treatment was acceptable to service users and therapists in At Risk Mental States for psychosis
services
 with qualitative feedback supporting the approach.
 The treatment may be particularly useful in preventing the progressions of psychosis
 as peoplewho have not developed fixed ideas about the origin of the experiencesmay bemore open to
alternative explanations
The concept of an At Risk Mental States (ARMS) for psychosis (Yung et al., 1996) was
introduced to describe individuals at elevated risk of developing later psychotic disorders.
ARMS has been operationalized in terms of three subgroups involving: (1) a brief episode
of psychotic symptoms, lasting less than 7 days, that remits without treatment; (2)
attenuated symptoms of psychosis; and (3) deterioration in functioning and a family
history of psychosis (Yung et al., 2005). Severalmeta-analyses (van derGaag, Valmaggia, &
Smit, 2014; Hutton & Taylor, 2014; Stafford, Jackson, Mayo-Wilson, Morrison, & Kendall,
2013;) have suggested that interventions in ARMS can reduce the conversion to psychosis
by 50%. These reviews, aswell as National Institute for Health andCare Excellence (NICE)
guidance (2014), recommended that people showing signs of an ARMS for psychosis
should receive Cognitive Behavioural Therapy (CBT). However, a later umbrella review,
noting the paucity of relevant evidence, suggested that no specific intervention has
demonstrated superior efficacy (relative to any other) in preventing psychosis in ARMS
individuals (Fusar-Poli et al., 2019).
Unusual sensory experiences like hallucinations are relatively common in the non-
clinical population, meaning people can have these with no need for care (e.g., Johns
et al., 2014; Toh, Thomas, Robertson, & Rossell, 2020). Nevertheless, hallucinations are a
key element of the presentations of help-seeking people attending specialist ARMS
services (O’Connor et al., 2016)meaning that, for some, hallucinations are distressing and
disabling. Auditory verbal hallucinations are also particularly associated with the risk of
developing psychotic disorders in clinically high-risk groups (Niles, Walsh, Woods, &
Powers, 2019). However, what leads someone to make the transition to illness is unclear.
It is not the presence of hallucinations alone, but is perhaps owing to precipitants such as
increases in current stressors or the experience of recent trauma (de Leede-Smith &
Barkus, 2013; Larøi et al., 2012), changes to cognitive appraisals, or increases in other
symptoms (e.g., anxiety, depression). It is doubtful that there is one single pathway to
psychosis,which represents a broad category of experiences and symptoms, but there are
likely to be dynamic interactions between hallucinatory experiences, delusional ideation,
sub-clinical negative symptoms, and affective changes that may predict subsequent
transition to psychosis (van Os & Reininghaus, 2016).
Consequently, an intervention for people in the ARMS category that specifically and
purposefully targets hallucinations may both help reduce the current frequency, distress
and impact on functioning, but could also help prevent the transition to a first episode of
psychosis. CBT for psychosis (CBTp) is helpful for dealing with voices to amodest degree
(Turner, Burgess, Smit, Valmaggia, & van der Gaag, 2020) and has benefits for a range of
other presenting issues like mood and anxiety. However, given the importance of
hallucinations in ARMS, there is scope to focus on these important symptoms and to draw
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on models of what leads people to see or hear things others do not, in order to help to
target causal mechanisms. Managing Unusual Sensory Symptoms (MUSE) is a novel
treatment which aims to improve outcomes through (1) increasing treatment specificity
by supporting understanding that hallucinations may arise from different cognitive and
perceptual processes); (2) drawing on current psychological models of how the brain
works, highlighting putativemechanismswhichmay be implicated in the development of
hallucinations; and (3) using technology to demonstrate key concepts, make the
treatment accessible and increase access to the intervention. For example, with regard to
subtypes of hallucinations, the concept of Hypervigilance Hallucinations (Dodgson &
Gordon, 2009), helps explain why expectancy or prediction can lead people to hear
things in ambiguous background noise, particularly when someone feels threatened
(Dudley et al., 2014). Along with other theoretical perspectives, MUSE draws on the
Predictive Processing Framework to explain how prior expectations can influence
perception and uses interactive tasks to highlight the importance of prediction to sensory
processing (Alderson-Day et al., 2017) but also how predictions can lead to errors
(Hohwy, Roepstorff, & Friston, 2008). The treatment was initially developed by clinicians
in Early Intervention in Psychosis (EIP) service in the North East of England, but has been
extended with input from the Hearing the Voice project, and the content reflects the
clinical and theoretical background to the manual. The treatment can be accessed via the
following link (https://web.ntw.nhs.uk/gsh/VH).
Initially the treatment was developed for people experiencing a first episode of
psychosis and was used as a brief intervention (4–6 sessions focussed on hallucina-
tions) within a larger package of psychological therapy as part of an initial feasibility
study (Dodgson et al., 2020). This showed the intervention to be acceptable, with high
scores for on the Satisfaction with Therapy and Therapist Scale (Oei & Shuttlewood,
1999). The feasibility study included participants from secondary care services who
had longstanding psychosis, and it was noted that clinicians from EIP services found
the intervention particularly helpful, consistent with higher rates of first-episode
participants completing the intervention. In addition, initial findings suggested that
MUSE appeared to be more effective for people who had not developed fixed or
delusional ideas about their experiences, which may become a secondary treatment
issue and, owing to processes like rumination (Lebert, Turkington, Freeston, & Dudley,
2020), may make people less open to alternative explanations. Finally, MUSE highlights
processes that may increase unusual sensory experiences, such as rumination, thought
suppression, and isolation after starting to experience voices, which may be addressed
in therapy. MUSE may thus be particularly suited to arresting the progression of
hallucinations, supported by the fact that feedback from clinicians who used MUSE
suggested it was particularly helpful for people in the early stages of their experiences.
These features of the package make MUSE potentially highly relevant for therapeutic
intervention in the ARMS population.
At Risk Mental States services are recommended to provide 10–16 sessions of CBT. In
the UK, however, not all areas have ARMS services, not all services can provide CBT and
not all people will accept or want CBT. A range of effective and accessible treatments are
therefore needed. The aim of the presentworkwas to conduct a feasibility study, with key
outcomesbeing acceptability (assessed by service-user and therapist interviews and rating
scales) along with recruitment, retention, and adherence to treatment. In addition,
outcome data were collected to identify which measures may be appropriate to use in a
definitive trial and also to identify if therewas a ‘signal of efficacy’ thatmay suggest that the
treatment may be effective.
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Method
Participants
Twenty-two participants were recruited from EIP teams in Tees, Esk & Wear Valley NHS
FT and Cumbria, Northumberland Tyne and Wear NHS FT. The average age was M
(SD) = 24.18 years (SD = 4.52), and 19 were male. 19 participants completed therapeu-
tic intervention and pre- and post-assessment measures, two participants transitioned to
first-episode psychosis prior to commencing therapeutic intervention and one transi-
tioned after starting therapy but prior to post-therapy assessment. While the former two
were excluded, the latter participant was nevertheless included in our analysis on an
intention-to-treat basis. Potential participants were identified from a cohort of service-
users commencing an ARMS pathway following a screening assessment using the
Comprehensive Assessment of At Risks Mental State (Yung et al., 2005). Services users on
the ARMS pathwaywhowere appropriate for cognitive behavioural therapywere offered
the opportunity to take part in the trial. Inclusion criteria for participation were meeting
criteria for ARMS,with auditory verbal hallucinations presenting as an attenuated positive
symptom; having identified hallucinations as target problem for psychological therapy;
and being aged 16 years or over. Exclusion criteria were organic basis for hallucinations;
intellectual disability; insufficient command of English language and primary diagnosis of
substance misuse. Participants received a gift voucher for completing the assessments.
Ethical approval for this study was given by NRES Committee Leeds East (REC Reference
Number: 18/YH/0433). The authors have abidedby the Ethical Principles of Psychologists
and Code of Conduct as set out by the APA.
Treatment manual
The therapists were provided with a treatment manual in a computer tablet format. The
manual contained eight modules. The first two modules (What are Voices and How the
Mind Works) were designed to inform about and normalize the experience of unusual
sensory experiences. The third module (Assessment) was designed to help identify the
relevant subtype of voices (the key criteria used are outlined in Dodgson et al., 2020).
Therewere also five treatmentmodules relating to different subtypes: Inner Speech - AVH
(IS-AVH), Memory Based-AVH (MB-AVH), Hypervigilance - AVH (HV- AVH), Visual
Hallucinations and Sleep. (See supporting informations for a list of the topics within each
module). Following service-user feedback in the previous study, MUSEwas redesigned to
enable the intervention to be service-user facing and made more flexible for therapists to
either linearly follow the treatment or to change the order based on their judgement. The
redesign was led by an expert-by-experience who is part of the research team (CG).
Trial therapists received a 2-day training course and monthly group supervision. Each
treatment section contains psychoeducationalmaterials inmulti-media format to illustrate
concepts and intervention approaches. Themanual was designed to be used in a bespoke
format driven by identification of relevant subtypes and individual service-user’s priorities
and preferences.
Procedure
Potential participants were identified at acceptance into the ARMS pathway or on referral
to the psychological therapists, andwere then approached by a Research Assistant (RA) to
discuss whether they were willing to participate. If interested in participating, the RA
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forwarded a Participant Information Sheet and arranged to meet the individual to further
discuss participation, complete the consent process and undertake the baseline
assessment. Psychological therapists were all accredited CBT practitioners with at least
2 years’ experience and were already working within the ARMS pathway. Therapists
were asked to provide an assessment and formulation to the participant and then to use
the manual in the first two to four therapy sessions, prior to therapeutic focus on other
target problems and goals unrelated to hallucinations. This design ensured that service-
users had adequate exposure to the treatment manual while also allowing for therapy to
address the primary goals and needs of service-user. On completing MUSE, the therapist
informed theRA,who then arranged to complete the post-treatment assessment. Thiswas
a small feasibility study and it was not possible to include a control group.
Outcomes
As this is a feasibility study, our primaryoutcomeswere referral, recruitment and retention
rates, acceptability of treatments (determined through assessing discontinuation rates,
service-user satisfaction, and qualitative analysis with participants’ and therapists’ views
on the treatment) and adherence to the MUSE intervention. To determine feasibility, we
applied 3-stage progression criteria (Avery et al., 2017) relating to recruitment, retention
to post-treatment assessment and adherence to MUSE. The progression criteria were
devised by the research group and are as follows:
1. Recruitment ≥80% of eligible participants consented into the study (green),
recruitment within 79–60% of consent (amber), recruitment <60% of consented
(red).
2. Retention of participants within the study with baseline and outcome assessments at
primary end point (end of treatment) ≥80% of primary outcome completed (green),
79–60% of primary outcome completed (amber), <60% of primary outcome
completed (red).
3. Satisfactory delivery of adherent therapy to ≥80% of participants receiving MUSE
(green), 79–60% of participants receiving MUSE (amber), <60% of participants
receiving MUSE (red). Satisfactory delivery of adherent therapy is operationalized as
completing at least one of the four unusual sensory experiences modules. Therapists
completed an adherence checklist after each session in order to track which
components of the manual were utilized.
Scales
1. Satisfactionwith TherapyandTherapist Scale (STTS;Oei& Shuttlewood, 1999), the
11-item scale was used to assess overall acceptability of the therapeutic interaction.
The measure includes questions relating to satisfaction with therapy and therapist
(e.g., ‘I am satisfiedwith the quality of the therapy I received’). The scalewas found to
have strong validity and reliability (mean Cronbach’s alpha = .90; Oei & Shuttle-
wood, 1999).
2. Psychotic Symptom Rating Scales: Auditory Hallucinations Subscale (PSYRATS;
Haddock, McCarron, Tarrier, & Faragher, 1999) is a clinician administered semi-
structured interview of hallucinations. The PSYRATS has been used extensively as an
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outcome measure in CBTp research in auditory hallucinations. The scale includes
detailed ratings of hallucinations (e.g., relating to frequency, duration or negative
content of voices), rated on a scale from 0 (‘No problem’) to 4 (‘Maximum severity’).
The scale shows good reliability and validity (Drake, Haddock, Tarrier, Bentall, &
Lewis, 2007).
3. The Comprehensive Assessment of At Risk Mental States (CAARMS; Yung et al.,
2005) is a clinician administered 27-item semi-structured interview that assesses
attenuated psychotic and psychotic symptoms. The CAARMS was designed to
identify the attenuated positive symptom thresholds necessary to fulfil ARMs criteria.
The perceptual abnormalities section was administered to assess hallucinatory like
experience in six sensory modalities. Examples of questions include: ‘Do you ever
hear things that may not really be there?’ or ‘Do you ever get strange feelings on, or
just beneath, your skin?’.
4. TheDepression, Anxiety and Stress Scales (DASS-21; Lovibond&Lovibond, 1995) is a
21 item self-report scale and was used to assess changes in symptoms of emotional
distress, stress, anxiety anddepression. It consists of 21 items (e.g., ‘I couldn’t seem to
experience any positive feeling at all’) that are rated on a Likert scale ranging from 0
(‘Did not apply tome at all’) to 3 (‘Applied tome verymuch ormost of the time’). The
scale shows excellent reliability and validity (Coker, Coker, & Sanni, 2018).
5. The short-form of the Choice of Outcome In CBT for psychoses (CHOICE;
Greenwood et al., 2010), is a 12-item service-user developed scale and was used to
assess progress post-intervention in achieving therapy-related goals. Examples of
items include statements relating to ‘Ways of dealing with distressing experiences
(e.g., beliefs, thoughts, voices)’ or ‘Positive ways of thinking’.
6. The Investigating Choice Experiments Capability Measure for Adults (ICECAP-A;
Flynn et al., 2015) was used to measure changes in recovery related functioning. It
comprises of five questions relating to five dimensions of wellbeing: attachment
stability, autonomy, achievement and enjoyment. Each statement is rated on a scale
from 0 (e.g., ‘I am unable to feel settled and secure in any areas of my life’) to 4 (e.g., I
am able to feel settled and secure in all areas of my life’).
7. The process of recovery (QPR Neil et al., 2009), is a 15-item service-user developed
scale used to assess recovery from psychosis outcomes framed in terms of the CHIME
principles. The items (e.g., ‘I feel that my life has a purpose’) are rated on a 5-item
scale, ranging from ‘Disagree strongly’ to ‘Agree strongly’. The questionnaire was
found to have strong validity and reliability (Law, Neil, Dunn, & Morrison, 2014).
All data from these scales that were used in statistical analyses are available to
download here: https://osf.io/h9rsp/?view_only=41e82d95b80e4be08f1242faa5b729f3.
Qualitative analysis
Each of the participating service-users and therapists completed a short exit interview
with a research assistant on completion of the study. To ensure consistency, a
structured interview was used, consisting of eight questions about the experience of
therapy (nine for therapists) and four questions on the experience of taking part in the
research. The questions were selected based on clinician and service-user feedback
from a study using a previous iteration of MUSE (Dodgson et al., 2020), focusing on the
overall experience of therapy, acceptability of the tablet, pros and cons of the
intervention, and their experience of research. Although service-users and therapists
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were asked slightly different questions in their interviews, their responses were
analysed together to explore points of overlap and divergence in their experience of
using the intervention.
Interview responses were then analysed by two researchers and a basic coding frame
was devised using a conventional content analysis in attempt to capture the main issues
brought up by participants (i.e., codes were not chosen in advance or dictated by theory,
as in directed content analysis; Hsieh & Shannon, 2005). However, because of the
structured nature of the interviews, and because we intended to report quantitative
summaries of the codes derived, our epistemological position was closer to a positivist
understanding more typically associated with quantitative content analysis (Krippen-
dorff, 2018).
Two researchers (CA and VP) independently developed descriptive codes for the
dataset. Codes were then discussed and refined, and a third researcher (BAD) was
consulted on code development. Both researchers then applied the agreed codes to 20%
of the dataset for parallel coding to ensure reliability, then the remaining data was coded.
Inter-rater agreement and reliability were acceptable to good (agreement = 91.62%,
kappa = 0.71). The subsequent codes were grouped into three main topics: using MUSE,
impact on clients, and impact on therapists. Each response could only receive each code
once, but each answer could have different meanings so it could fit across multiple
categories. Development, analysis and reporting of codes was conducted bearing inmind
the positions of the two coders – one a clinical psychologist, the other a public
engagement and involvement expert. This may have influenced their analysis by
foregrounding issues of service-user understanding, positive feedback, and accessibility.
Both reviewers were particularly interested in whether the intervention provided clients
with newways of understanding their experiences, had a normalizing effect, and reduced
self-stigma and feelings of isolation.
Results
Twenty-six participants were identified as eligible with 22 consenting (84% recruitment,
green zone) and 19 participants completing therapeutic intervention and pre and post-
assessments (86% retention, green zone). The high recruitment rate ensured that the
participants reflected the referrals to the service and resulted in a high proportion of male
participants (86%), as would be expected in a service aiming to reduce the onset of
psychosis. Recruitment and retention were high through the trial, possibly reflecting
rapid access to an intervention that directly targeted the participant’s reason for help
seeking. In the exit interviews, 79% of participants suggested that theywould have agreed
to participate even if theymay have been randomized to treatment as usual condition.One
participant transitioned to first-episode psychosis prior to commencing therapeutic
intervention and one transitioned after commencing therapy, but prior to post-therapy
assessment: baseline data for the latter was therefore taken forward and included in the
final analysis on an intention to treat basis. Figure 1 shows the CONSORT diagram for the
study. Referral rate was above prior expectations enabling the study to close for
recruitment earlier than expected. The participant who did not complete the treatment
was transferred to the FEP pathway, after their mental health deteriorated following a
relationship breakdown; this was recorded as an Adverse Event, in accordance with the
Standard Operating Procedure from the Sponsoring Trust, and based on NIHR Guidance
(this was the only reported Adverse Event in the study).
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Adherence checklists were completed in order to help assess feasibility of delivery of
MUSE. Checks were completed for 17 service-users in the study (see Table 1). On average
therapists used 3.94/8 modules during treatment, with one AVH subtype being the mode
number used in 8 cases (7 used two subtypes, one used all three subtypes, and one only
focused on the visions module). The progression criteria were met, with 17 (85%
adherence, green zone) of service-users completing at least one unusual sensory
experiencemodule. As Table 1 indicates, the introductory modules on ‘What are voices?’
and ‘How themindworks’ were used in almost all cases, typically by session 2–3with the
†First Episode in Psychosis pathway 
Eligible for the study (n= 26) 
Consented into the study (n= 22) Recruitment 
Baseline assessment (n =22)Baseline 
Reasons for not compleng: 
- Transferred to FEP† pathway 
without starting treatment (n = 1) 
- Did not start treatment (n = 1) 
Follow-Up 
Reasons for not compleng: 
- Transferred to FEP† pathway (n = 1)
Started Treatment (n =20)
Treatment 
sessions 
Follow-up assessment (n = 19)
Figure 1. Completion flow diagram for participants recruited, receiving treatment, and completing
MUSE. †First Episode in Psychosis pathway.
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service-user. Inner speech was the AVH subtype used most, followed by hypervigilance
and memory subtypes. When a module was selected, the vast majority of topics within
that module were reported as being used, with the exception of the hypervigilance and
visions modules, where some modules repeated content from earlier modules.
Qualitative analyses
Table 2 displays the codes used to classify responses from both clients and therapists.
Using MUSE
Five of the therapists and 10 of the service-users made positive comments about how the
treatmentwas easy to use, with only one negative comment from a therapist. Apart from a
few technical issues (relating to volume, device battery life, andWi-Fi access), the delivery
of the therapy was simple and straightforward. Therapists found the manual well-
structured and well-organized, specifying that there was a clear pathway through the
modules, and that psychoeducationmaterials weremostly easy to find. For therapists, the
modular format of MUSE improved the structure of sessions and helped to keep focus.
Three therapists reported difficulties navigating the manual, emphasizing that finding
information quickly and efficiently required a degree of training and preparation.
All therapists and service-users found the informational content of MUSE to be highly
useful and relevant to their needs. For clients, ‘talking about my problems in my past life
and how it’s affecting us in the present day. It showed us that. . .your mind can play tricks
on ya and sometimes you think other people are talking about ya, but it’s not, it’s just your
mind putting these thoughts into your head’ (P2). The intervention provided newways to
understand unusual experiences, facilitating insight into the way in which hallucinations
can be linked to previous life events (e.g., trauma), and cognitive processes such as inner
speech, memory and the role of prediction in perceptual processing. Therapists reported
that MUSE was a useful and effective clinical tool. Consolidating psychoeducation
materials and resources in one device provided a toolkit ‘that you can just dip in and dip
out of when you want any examples . . . a really good clinical tool.’ (T3)
Table 1. Adherence to therapy across MUSE modules
Module Used (N = 17)
Mean
Topics (%) First session used
Introductory
What are voices? 14 98.57 2.43
How the mind works 17 98.82 2.94
Assessment 9 100.00 4.56
AVHa subtypes
Inner speech 15 85.13 5.13
Memory 2 100.00 7.50
Hypervigilance 8 50.00 5.75
Additional
Visions 4 61.54 4.00
Sleep 2 100.00 3.00
Note. aAuditory verbal hallucinations.
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Table 2. Using MUSE
Description
Service-users n = 19
Therapists n = 7
Example
MUSE was simple and
straightforward to use
Service-users (10 Positive, 0 Negative comments)
‘Piece of cake!’ (P16)
‘The actual tablet usingwas straightforward . . . and itwas good to be
able to look at the videos and stuff as well, from the actual like
research’ [P 9].
‘It made it easier than like just having like loads of papers and loads of
forms and stuff like that . . .’ (P 15)
Therapists (5 Positive, 1 Negative comment)
‘It was really easy to be able to dip in and out of modules, being able
to kind of findwhat I needed to find, so it was actually quite easy to
use’ (T 1)
‘. . .there were a few kind of like just . . . just minor issues, things like
sound . . . things like the videos.’ (T 7)
MUSE was well-structured and





were easy to find
Service-users (1 Positive comment)
‘. . . it was good, it was structured, it seemed to be going
somewhere’ (P 9)
Therapists (5 Positive and 1 Negative comment)
‘I liked the way that it provided a gradual build of the service-users’
knowledge and . . . allowed them to kind of develop from standing.
What was specifically helpful for mewas that it reassuredme that I
hadn’t missed anything’
(T 7)
‘I think sometimes things come up and you’re thinking, oh that’s in
that other bit, and . . . it kind of loses something if you’re there
going, right, I just need to find . . .’ (T5)
Therapists (5 Positive and 1 Negative comment)
‘I liked the way that it provided a gradual build of the service-users’
knowledge and . . . allowed them to kind of develop from standing.
What was specifically helpful for mewas that it reassuredme that I
hadn’t missed anything’
(T 7)
‘I think sometimes things come up and you’re thinking, oh that’s in that
other bit, and . . . it kind of loses something if you’re there going, right, I
just need to find . . .’ (T5)
MUSE content was useful and
relevant to the clients and
therapists’ needs
Service-users (19 Positive, 1 Negative comment)
‘It helpedme understand different stuff. . . .Yeah, where voiceswere
coming from and what they meant’
(P 6)
‘Yeah, it was really good, ehm, really helpful, ehm . . . you got to see
like different reasons for why I was like hearing voices and stuff. So
it was really helpful for me’. (P 7)
Therapists (7 Positive comments)
‘it was really nice having an iPad that you just carry, you just take it
out and you just open it up and use. And kind of having lots of clips
and different things that you know we were able to use’.
(T 3)
Continued
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Table 2. (Continued)
Description
Service-users n = 19
Therapists n = 7
Example
‘I just found it a really, really useful tool, sort of really relevant to the
client group, you know an easy process to follow with the slides
and the assessment modules’ (T 2)
The information on MUSE was
accessible and easy to understan
Service-users (7 Positive, 5 Negative comments)
‘I like watching videos, I think it was easier to understand than when
she [the therapist] was talking’.
‘Erm . . . because you kinda have images, videos, you kinda . . .. Like
learn a little bitmore than if you just did it like through talking or . . .
you took in a bit more’.
(P 15)
‘I think some of the like kind of metaphorical language just comes
across a bit patronising . . . I think that there’s some ways you can
try and make it kind of more . . . personal or easier to understand’
(P 19)
‘the information in it is very good, the delivery of it’s pretty poor . . ..’
(P 12)
Therapists (3 Positive, 2 Negative comments)
‘Someof the things that I found harder to explain verbally orwithout
a . . . visual prompt, they came across so much better being well
prepared on the slide. Even things that were actually quite simple
you could see the patients kind of really getting it from . . . it being
in written down form or picture form’.
(T 6)
‘I think it was pitched at the right level to sort of get a large group of
people really’
(T 6)
‘I mean my . . . guy, I don’t think he’s probably got the highest
intellectual sort of ability as . . . so I think some of the things were a
little bit . . . academic for him’ (T 3)
The information and multi-media
resources embedded in MUSE
were interesting and engaging
Service-users (10 Positive, 6 Negative comments)
‘It was good, it was interesting . . . because you kinda have images,
videos’ (P 15)
‘The videos on the tablet . . . they were a bit long and . . . well they
were just very boring’ (P 10)
Therapists (3 Positive comments)
‘It was nice having the different clips that kind of talked about things
and . . . I think those were the things that people like’ (T 4)
‘the things that my patient really loved with the videos were the
things that he could participate in doing’ T3.
MUSE requires training and
preparation before use with
clients
Service-users (1 Positive comment)
‘I wouldn’t recommend diving straight in on a tablet, you know with
someone that you hadn’t spoken to, therewas a good few sessions
that we had before we even . . . you know looked at the . . . the
programme, which I think is definitely needed, otherwise you’re
just sat in a room with a person you don’t know, looking at a
computer screen’.(P 9)
Continued
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The majority of comments were positive about the material being accessible, easy to
understand, and presented suitably for the target audience. For therapists, one of the
advantages was that the multi-media resources (e.g., videos and talking points) ‘allowed
me to do is to deliver some quite complex concepts in a really kind of accessible way’ . . .
(T7).
Clients also commented that MUSE made psychoeducation materials easier to grasp
‘because you kinda have images, videos, you kinda . . .. like learn a little bitmore than if you
just did it like through talking’. (P15)
However, five service-users suggested that MUSE content was inaccessible because it
was presented in an alienating language or style: ‘If you’re not very good at classroom
learning . . . I don’t think it is going to appeal’ (P12). Two of the therapists raised a similar
concern, suggesting that some content was too ‘academic’ for their clients.
Finally, most of the therapist and service-users comments reported that MUSE was
interesting andengaging,with clients noting that the videos and interactive activitieswere
particularly enjoyable. However, six service-users described the resources as ‘boring’ or
‘repetitive’. Nevertheless, 94.7% of clients and 100% of therapists stated they would
recommend MUSE to others, which tallied with the service-users overall satisfaction
scores on the STTSwhichwere very good,with amean score of 49.47 (SD = 5.60) out of a
maximum of 55 (mean item response = 4.50/5, indicating strong agreement).
Table 2. (Continued)
Description
Service-users n = 19
Therapists n = 7
Example
Therapists (4 Positive comments)
‘I think it takes a bit of time to get used to, and you certainly need to
have done some prep . . . you couldn’t go into the session having
not kind of got your way round it’.
‘. . . as long as you sort of flick through it before the session and think
about what vague area you were going to be going on, it was easy
enough to find the bits that were relevant towhat youwere talking
about’. (T 3)
‘I think if I’d started off with the tablet, I think it might have impeded
my ability to build a relationship with him. But because I’d already
had a relationship . . . I think it was sort of an OK took to be using,
but I don’t think I’d have liked to have used it from day one because
then I think it might have hindered it a little bit’. (T3)
Therapists and clients would
recommend MUSE as an
intervention for people with
psychosis
Service-users (18 Positive, 1 Negative comment)
In answer to the question, would you recommend MUSE to others:
‘Completely. Because it showed me that . . . it wasn’t just me
thinking of these things, it was showing us . . . that it was . . . my
mind playing tricks on us’. (P 2)
‘No. . ..Purely on the delivery of it’. (P 12)
Therapists (7 Positive comments)
‘Yeah, absolutely, yeah. It’s definitely something that I think could be
. . . be used quite a bit, especially in EIP definitely’. (T 1)
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Impact of MUSE
Tables 3 and4 show thatMUSEhad several impacts thatwere shared by both service-users
and therapists. High numbers of service-users and therapists reported that the tablet
increased engagement with therapy, making it easier to form a strong therapeutic
relationship, improving interest and attendance, and helping clients to feel less anxious.
For some clients, MUSE prompted engagement with therapy outside sessions, inspiring
them to research topics and additional sources of support.
Several service-users and therapists reported that MUSE improved communication,
making it easier for clients to share their feelings and experiences, and providing starting
points for discussion. Therapists commented that the tablet-based resources lent





Personal stories and other
resources embedded in MUSE
reduced self-stigma and feelings
of isolation
8 Positive, 0 negative comments
‘Yeah, finding out you’re not the only person in the world hearing
voices, and that you’re not actually going insane’ (P 1)
‘. . . makes them [the voices] seem you know far more explainable
than they were. Beforehand it was like this weird, whacky kind of
green thing thatmakes you a complete nutcase and now it’s like . . .
feedback in the brain or something that can be explained, which is
good’. (P 9)
Use ofMUSE reduced anxiety and
improved ways of coping and
living with unusual experiences.
Voices sometimes disappeared
altogether
8 Positive, 0 negative comments
‘It helpedme to remain calmwhen I experience . . .oh I can’t think of
the word . . . the way that I feel I guess . . .’(P13)
‘. . . it made sense like why the voices were happening, now they’re
not there anymore. Yeah, it made a lot of difference’. (P 17)
MUSE was more effective and
engaging than other talking
therapies (e.g., standard CBTp)
11 Positive, 2 negative comments
‘I just think it is a lotmore helpful than just sitting talking to someone’
(P 18)
‘Personally, I think that . . . using the tablet is more beneficial than
not using the tablet. . . . [People who don’t have the tablet] can’t
see . . . like they can’t visualise and hear what’s going on . . . like
what the tablet’s about, like what’s entailed with the therapy’ (P 4)
MUSE facilitated a strong working
relationship with the therapist,
reduced anxiety and increased
engagement in sessions
18 positive, 2 negative comments
‘I didn’t feel like I was sat in a prison cell. Being interrogated by . . . I
felt like it was more . . . that I was not going to like a meeting, but I
was more like . . . didn’t feel like I was on edge as much’. (P 3)
‘Rather than sitting there and talking with the therapist, I was
spending the majority of time reading something, then asking
questions and getting answers’. (P 12)
MUSEmade it easier for the client
to communicate their feelings
and experiences and provided
starting points for exploring
issues in more depth.
6 Positive, 1 negative comment
‘. . . it helped him [my therapist] I think almost like relate a bit more
to what I was trying to say, because sometimes I found it hard to
kind of work out what I wanted to . . . to say or I found it hard to
explain something. So if we were going through the table, it was
easy for me to just point . . .’ (P 7)
‘I’d be very confused about what we were talking about’ (P 14)
Continued
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Use of MUSE enhanced
therapists’ knowledge, skills,
and confidence in working with
people who have unusual
sensory experiences
5 Positive, 0 negative comments
‘. . . forme as part ofmy kind of learning and kind of understanding of
things . . . getting access to the resources . . . was really, really
helpful. And actually, frommy perspective, that’s helped you know
kind of my development as a therapist’. (T 4)
‘What was specifically helpful for me was that it reassured me that I
hadn’t missed anything. . . .And I like reassurance that I’ve . . . been
thorough and as robust as I can be, and so it . . . provides me with
the reassurance that the service user had gained what he needed
to, and obviously that it was evidence based’. (T 7)
The psychoeducation materials
and structure of MUSE
improved the way the therapist
developed a formulation for the
client.
7 Positive, 0 negative comments
‘I was able to look at the theory, talk to the service user about kindof
how that fit with their experiences, make some notes that we then
like added to the formulation, rather than doing the formulation
just in one session, it was kind of growing every week. So I do think
it helped with that’. (T 1)
‘justworking yourway through thosemodules and then allowing the
time to reflect on the . . . on the service-users’ experiences. So
yeah, it did definitely help with the formulation’ (T 2)
MUSE can be adapted to
individual needs and allows
therapy to be more client led
5 Positive, 0 negative comments
‘What I did was I allowed the service user to drive the tablet and
therefore to drive the pace as well. . . . And I think that gave them
some ownership over the process’. (T 7)
‘I quickly learned that I needed to go on a different pace for . . .
people in terms of their understanding. So for some people we
would kind of go through a module each session, for other people









improved trust in psychological
and neuroscientific explanations
of unusual experiences
2 Positive, 0 negative comments
‘If I hadn’t seen like the stuff on the tablet about how ya mind can
make different things, I wouldn’t have been able to understand it
better in a sense because . . . yeah, I’m getting told these things off a
person but . . . how do I . . .where’s like the proof that I can look at
to say, right, I can understand that, I can go through it and then . . . it
all links up together, which you don’t get that if you’re just talking
to someone, you don’t physically get to look at it and see . . . the
ways in which it works’ (P 2)
‘It showed me that she wasn’t just telling us all this, it was proof on,
not paper but obviously a tablet’. (P2)
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legitimacy and credibility to psychological and neuroscientific explanations of unusual
experiences, ‘So it was some random person saying it, not just my therapist who I was sat
with who kind of has to say that’ (P2).
Impact on service-users. A number of service-users described the manual as having a
specific impact on them (see Table 3). Normalization was a key theme to emerge, with
eight service-users volunteering that MUSE contributed to a reduction in feelings of
isolation, for example P7 suggested that ‘other people talking about their own experience
justmade you feel like youweren’t by yourself’ and self-stigma, ‘Beforehand itwas like this
weird, whacky kind of green thing thatmakes you a complete nutcase and now it’s like . . .






quite easy to . . . to work out, depending on who I was talking to’.
(T 1)
MUSE increased engagement in
sessions, improved the
therapeutic relationship and
helped clients to feel more
comfortable
6 Positive, 0 negative comments
‘. . . it did help with the relationships, got really positive feedback
from it. Attendance rate was quite good, so that’s always a good
sign’ (T 2)
‘. . . youwere kindof directing your attention to the device, so I think
people felt more comfortable with what we were talking [about]
because it wasn’t like having to have that kind of eye contact and
things’. (T 1)
MUSE improved communication
between therapist and client,




4 Positive, 0 negative comments
‘I think what it allowed me to do is to deliver some quite complex
concepts in a really kind of accessible way. And it’s . . . so most of
the stuff was . . . the content was content that I was aware of but I
don’t think that I was particularly succinct or articulate in
explaining them to patients’ (T7)
‘It was really handy to have it as something that could start
discussions on things’ (T 4)
‘I think what was useful was being able to use the tablet to start off a
conversation using the theory but then being able to kind of adapt
that to people’s personal experiences. So kind of using that as a
starting point but then being able to have a conversation following
out of that’ (T 1)
MUSE legitimized therapists’
explanations of why unusual
experienceswere occurring and
made them more powerful
4 Positive, 0 negative comments
‘I think feedback from clients is [they] kind of like . . . the kind of . . .
legitimacy of something that’s on a computer. So . . . [one of the
clients] said ’oh I’m not being funny but like . . . it’s more believable
him saying it on the video, than . . . just you and I talking about that
. . .’ There’s something about being a product, it being something
that’s like . . . like produced in thatway that people perhaps find the
information a bit more compelling than they would if it’s just in a
dialogue’. (T 5)
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Service-users also reported that the intervention enhanced daily functioning and improved
ways of coping with unusual experiences. Significantly, one participant no longer heard
voices after the treatment: ‘. . . itmade sense likewhy the voiceswere happening, now they’re
not there anymore . . . it made a lot of difference.’ (P17)
Ten service-users made positive comments that ‘Using the tablet is more beneficial than not
using the tablet. . . . [People who don’t have it] . . . can’t visualise and hear what’s going on . . .
like what’s entailed with the therapy.’ (P4)
Only two service-users suggested that they preferred other forms of talking therapy to
MUSE, citing difficulties concentrating and a preference for less structured forms of
therapy as reasons.
Impact on therapists. For therapists, MUSE offered a number of benefits (see Table 4).
Five reported that it increased their knowledge, skills, and confidence, for example T6
stated ‘I can see that [it’s] affected all of my practice . . . It’s improved my knowledge, it’s
improved my confidence and . . . I think the patients get a lot out of the way it’s
represented’.
All therapists agreed that MUSE improved formulation development. Firstly, the
manual’s modular structure provided a ‘step-by-step’ approach to understanding the
factors underlying the clients’ experiences. Secondly, the explanations of different AVH
subtypes in MUSE allowed for greater specificity in the formulation.
Adaptability was another significant theme. Five therapists said that MUSE can be
adapted to individual needs, enabling therapy to become more client led. It is possible to
progress through the modules at different speeds, allowing the service-user to ‘set the
pace’ and to pick and choose the materials they would like to explore in more depth. No
therapist reported any negative impacts. One concluded that, in their view, clients
responded better to MUSE than to standard CBT ‘Users responded well to the iPad . . .
possibly more so than . . . your CBT that you normally do’ (T2).
It was also noteworthy that participants spontaneously made comments that
supported the underlying rationale for MUSE. Firstly, feedback suggested that the
subtypes were meaningful to participants, ‘so I remind myself that I could just be being
hypervigilant and just listening out for noises in/andmy brain creating noises. . .which has
helpedme remain calm’ (P13). Secondly, MUSE draws on current psychologicalmodels of
how the brainworks and attempts to explain often complex theories thatmay explain the
mechanisms implicated in the development of hallucinations. For example, P15
suggested ‘Yeah, yeah, it definitely helped me understand a lot of like . . . ehm . . . where
it was coming from and it was more internal for me than it was like . . . maybe external’.
Therapists and participants clearly valued access to material that made these theories
more accessible, ‘If I hadn’t seen like the stuff on the tablet about how ya mind can make
different things, I wouldn’t have been able to understand it better in a sense because . . .
yeah, I’m getting told these things off a person but . . . how do I . . .where’s like the proof
that I can look at to say, right, I can understand that, I can go through it and then’ (P2).
Thirdly, the use of technology is supported in the quote above and there were several
references to how seeing things helped understanding. Interestingly, it also seemed to
give additional weight to the content, that it had been put on a tablet, ‘It showed me that
she wasn’t just telling us all this, it was proof on, not paper but obviously a tablet’ (P2).
One therapist said ‘[one of the clients] said ’oh I’m not being funny but like . . . it’s more
believable him saying it on the video, than . . . just you and I talking about that’. The
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modular structure also promoted a consistent and thorough intervention ‘just working
your way through those modules and then allowing the time to reflect on the . . . on the
service-users’ experiences. So yeah, it did definitely help with the formulation’ (T2).
Changes in symptoms
To explore the appropriateness of measures for further trials, baseline and follow-up
scores of auditory hallucination total, distress total and delusions total from the PSYRATS,
were identified as likely primary outcome measures (see Table 5). PSYRATS scores
showed similar reductions, with the largest change being observed for auditory
hallucinations total score (d = 0.77). Despite a medium effect size (d = 0.42), delusion
scores on the PSYRATS did not significantly reduce from baseline, although it should be
noted that only 5/22participants scored above zero at baseline on thismeasure, and two at
follow-up (suggesting insufficient incidence of delusional ideation in this ARMS cohort).
Comparisonsweremade on the other outcomemeasures including the auditory and visual
items of the CAARMS. Each of the CAARMS outcomes showed significant reductions from
baseline, with the largest effect sizes being observed for auditory and visual severity
ratings (d = 0.70–0.77), and, notably, improvements in current functioning scores
(d = 1.55). There were no clear differences in improvement for auditory compared to
visual experiences. Improvements in DASS scores were also significant, with the largest
reductions being observed for depression scores (d = 0.87).
Table 5. Outcome measures
Baseline Follow-up
p dM SD M SD
CAARMSa
Auditory severity 4.60 1.23 3.15 2.18 .003 0.77
Auditory frequency 3.60 1.47 2.55 1.88 .023 0.55
Auditory distress 67.50 27.70 44.25 40.14 .016 0.59
Visual severity 3.20 1.64 1.75 1.89 .005 0.70
Visual frequency 2.90 1.52 1.90 2.15 .025 0.54
Visual distress 50.85 36.62 21.00 34.93 .008 0.66
SOFAb (Current) 53.60 9.13 68.00 14.46 <.001 –1.55
PSYRATSc
Auditory Hallucinations 26.30 9.16 17.25 13.33 .003 0.77
Distress 13.90 5.56 9.45 7.19 .010 0.64
Delusions 3.25 5.95 1.55 4.78 .077 0.42
DASSd
Depression 12.75 5.35 8.20 5.16 <.001 0.87
Anxiety 11.25 4.98 8.50 5.10 .020 0.57
Stress 14.05 4.61 10.35 5.15 .012 0.62
ICECAP-A (tariff)e 0.51 0.19 0.66 0.19 .004 –0.73
CHOICEf
Mean severity 3.99 1.36 5.86 1.91 <.001 –0.88
Mean satisfaction 3.39 1.68 5.98 2.45 <.001 –0.94
Notes. aComprehensive Assessment of At Risk Mental States.; bSocial and Occupational Functioning
Assessment Scale.; cPsychotic Symptom RATing Scale.; dDepression, Anxiety and Stress Scale.; eICEpop
CAPability measure for Adults.; fCHoice of Outcome In Cbt for psychosEs.
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Post-treatment mean score on the QPR was 40.63 (10.94), representing 67.71% of
maximum score, or a mean response of 2.71/4. While this may seem a relatively modest
level of recovery, scores for capability nevertheless significantly improved on the ICECAP-
A tariff (d = 0.73). Moreover, scores on the CHOICE (in which participants rate their
goals for therapy and recovery, and can specify their own aims from treatment) showed
some of the largest shifts from baseline, with effect sizes above 0.9. The measures used
appeared appropriate except for the delusions scale of the PSYRATS, which was only
attempted by 16/19 people at follow-up, and with many participants scoring zero. Aside
from this measure, there was a 100% completion of scales among those completing
follow-up.
Discussion
The main aim of this study was to understand the feasibility and acceptability of MUSE to
service-users and therapists. Recruitment and retention rates from this study met the
green zone criteria and suggested that it was feasible to recruit to the study and retain
people in it. Moreover, adherence data indicated that participants worked on hallucina-
tion-related content. From this it was evident that MUSE was acceptable to ARMS service-
users. Also, high scores on the STTS suggested good satisfaction with the treatment and
therapist, which was supported by the qualitative feedback. 95% of participants said they
would recommend the intervention to other service-users and there was very positive
feedback on the impact of the treatment, with several comments suggesting that MUSE
had succeeded in normalizing hallucinations and creating an alternative explanation of
the experiences that reduced distress and improved functioning. Therapist feedback was
positive and suggested that they had found MUSE easy to use, it had improved
communication and engagement, and that they felt it had improved their knowledge and
the quality of their formulations.
The measures showed a consistent reduction in scores at post-treatment, suggesting
that they can demonstrate change. There was a promising signal of efficacy, with most
measures showing a large effect size, although the absence of a control group means that
this could be regression to themean or improvement over time, so no claims can bemade
about the effectiveness of the treatment. MUSE directly targets hallucinations, but there
were reductions in post-treatment scores for depression, anxiety and functioning,
suggesting that the changes in hallucinations may have generalized to other areas. The
limited scope of this feasibility trial meant that we were not able to track conversion to
psychosis over an appropriate follow-up period. One participant converted to psychosis
during the trial.
NICE guidance (2014) recommends that people meeting ARMS criteria should be
referred for specialist assessment and offered CBT, with or without family interventions
and treatment for co-morbidities such as anxiety or depression. However, Fusar-Poli et al.
(2019) suggest that there is not sufficient evidence to recommend any specific treatment
for ARMS, so there is a pressing need to develop effective treatments in this area,
particularly as current NHS policy in England is to ensure that ARMS services are
commissioned (NHS LongTermPlan, 2019). CBT involves developing a formulation of the
individual and would often include identifying significant factors, such as childhood
sexual abuse and how thismay contribute to the development of psychosis (Hardy, 2017).
MUSE attempts to create a more detailed understanding of the psychological mechanisms
that underlie voice-hearing, and therefore creates a more detailed formulation with
498 Guy Dodgson et al.
additional treatment options. MUSE is therefore fully compatible with CBT, with most
therapists offering further CBT based interventions after completing MUSE. The modular
structure of MUSE enables skilled clinicians to flexibly use it as part of a CBT intervention
or as a stand-alone intervention. Moreover, MUSE is also suitable for use by non-therapists
and further research is planned to assess the feasibility of non-therapists delivering MUSE,
which could significantly increase access.
Interestingly, the results also supported the novel aspects of MUSE. Firstly, the
adherence checklist showed that therapists used the subtyping structure to tailor their
interventions, with Inner Speech being the most used module, consistent with previous
research on the frequency of subtypes (Garwood, Dodgson, Bruce, & McCarthy-Jones,
2015). The feedback from several of the participants directly stated the benefits of this
approach. Secondly, both therapists and service-users commented that MUSEmade more
understandable complex psychological models that may be implicated in the develop-
ment of hallucinations. This knowledge can help strengthen the credibility and
acceptability of the explanation offered by the therapists as to why people see or hear
things (Currell, Christodoulides, Siitarinen, &Dudley, 2016). However, some participants
still found the videos ‘boring’ suggesting that the presentation of information could still be
improved. Thirdly, several benefits of using a tablet were outlined, including helping to
make complex theories accessible, that the modular structure promoted consistency and
helped in the development of compelling formulations. An unexpected benefit was that
service-users found information being presented on a tablet, rather than by a therapist,
more believable.
The reformulation of hallucinations may impact on the progression of hallucinations,
through reducing frequency, distress and preventing the development of delusional
explanations for the experience (Maher, 1974), all factors that increase the scores on key
diagnostic criteria (PANSS, Kay, Fiszbein, & Opler, 1987; CAARMS, Yung et al., 2005).
Previous research had suggested that people with strong delusional beliefs, were less
likely to benefit from this approach (Dodgson et al., 2020), but in this study only a small
number of participants had delusional beliefs, as rated on the PSYRATS, and these scores
had reduced at follow-up, suggesting that MUSE may be particularly suited to the ARMS
group. Indeed, this detailed psychoeducation may also have value earlier in the
development of hallucinations and may be used to explain anomalous sensory
experiences before they become entrenched.
There were several limitations to this study. The absence of a control group precluded
testing randomization and blinding procedures and makes it impossible to interpret any
signal of efficacy. Recording sessions and rating them for adherence would have formed a
better measure of adherence than therapist’s ratings of the modules they have used.
However, themodular structure of MUSE is likely to promote adherence to the treatment.
Norwas the study able to collect key outcome data on conversion to psychosis and health
resource utilization.
In conclusion, this study demonstrated that MUSE was acceptable to participants
meeting the green criteria for recruitment and retention, and qualitative feedback was
positive about the intervention. Qualitative feedback supported the underlying assump-
tions of the intervention, in that subtyping of hallucinations, drawing on possible
mechanisms from current psychological theories, which are made accessible through
using technology, can have benefits for service-users, particularly at the early stage of
experiencing unusual sensory experiences.
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